Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions TARRYTOWN, N.Y., July 1, 2022 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has completed […]
SAN FRANCISCO , July 1, 2022 /PRNewswire/ — Telegraph Hill Partners (THP), a venture capital and growth equity firm dedicated to building life science and healthcare technology businesses, announced that it has closed on THP […]
SAN FRANCISCO, July 1, 2022 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced the promotion of Jillian B. Thomsen to Senior Vice President (SVP) & Chief Financial Officer. Ms. Thomsen has served as SVP, Finance […]
Paul Moore ? Zymeworks used a poison pill maneuver a couple weeks ago as the counterpunch to a $773 million takeover bid by All Blue Falcons, and new CEO Kenneth Galbraith isn’t done piecing the […]
The promise of new drug therapies still exists in Buffalo, but the challenges are severe. Click here to view original post Click here to view original post
Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses. Click here to view original post
SAN DIEGO — From San Diego to New Jersey, biotechs developing new forms of birth control say they’re doubling down on those efforts after Roe v. Wade was overturned — even as the Supreme Court’s […]
Happy New Year! Event Announcements & Most Viewed 2021 News 2021 was again quite a year with the challenges presented by the COVID-19 pandemic. Biotech Networks launched its first US east coast hub in Boston/Cambridge as well […]
Scientists used an oddball molecule made by bacteria to develop a new class of biofuels predicted to have greater energy density than any petroleum product, including the leading aviation and rocket fuels. The post Bacteria […]
© 2022 Biotech Networks, LLC
